These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4427254)

  • 21. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicompartment-kinetics and the accumulation plateau.
    van Rossum JM; Tomey AH
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):200-3. PubMed ID: 5485099
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugs.
    Hayes AH
    Clin Pharmacol Ther; 1974 Jul; 16(1):201-11. PubMed ID: 4843316
    [No Abstract]   [Full Text] [Related]  

  • 24. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies.
    Smyth RD; Hottendorf GH
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):179-95. PubMed ID: 7394763
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between dose, effect, time, and biophasic drug levels.
    Smolen VF; Barile RG; Theophanous TG
    J Pharm Sci; 1972 Mar; 61(3):467-70. PubMed ID: 5013390
    [No Abstract]   [Full Text] [Related]  

  • 26. Clearance and infusion.
    Plusquellec Y
    Eur J Pharm Biopharm; 1998 Mar; 45(2):205-6. PubMed ID: 9704918
    [No Abstract]   [Full Text] [Related]  

  • 27. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 29. New compartment- and model-independent method for rapid calculation of drug absorption rates.
    Chiou WL
    J Pharm Sci; 1980 Jan; 69(1):57-62. PubMed ID: 7354444
    [No Abstract]   [Full Text] [Related]  

  • 30. Rate-controlled drug delivery.
    Goldman P
    N Engl J Med; 1982 Jul; 307(5):286-90. PubMed ID: 7045668
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical pharmacokinetics (second of two parts).
    Greenblatt DJ; Koch-Weser J
    N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of infusion pump fill-stroke flow interruptions on simulated serum concentrations of short half-life drugs.
    Floyd RA
    Am J Hosp Pharm; 1984 Nov; 41(11):2399-400. PubMed ID: 6507446
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimation of pharmacokinetic parameters from postinfusion blood level data obtained after simultaneous administration of intravenous priming and infusion doses.
    Singhvi SM
    J Pharm Sci; 1977 Oct; 66(10):1499-501. PubMed ID: 925916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of parenteral drugs II. Parenteral doses other than intravenous and intramuscular routes.
    Tse FL; Welling PG
    J Parenter Drug Assoc; 1980; 34(6):484-95. PubMed ID: 6906371
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified derivation of Chiou-Hsu equation for rapid estimation of total body drug clearance during constant-rate intravenous infusion.
    Chiou WL
    J Pharm Sci; 1978 Dec; 67(12):1776-7. PubMed ID: 722504
    [No Abstract]   [Full Text] [Related]  

  • 37. Keeping bioavailability in perspective.
    Schumacher GE
    Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug preparation interactions with food, gastrointestinal tract microflora and with themselves when parenterally administered].
    Kudrin OM; Davydova ON
    Farm Zh; 1978; (2):48-53. PubMed ID: 658341
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biologic availability of drugs in humans and animals].
    Wichliński L
    Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application of clinical pharmokinetic principles in the adjustment of drug dosage].
    Dugal R; Bertrand M
    Union Med Can; 1975 Jun; 104(6):960-9. PubMed ID: 1224416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.